BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 34909917)

  • 1. Oral pilocarpine for the treatment of dry eye in patients with Sjögren's syndrome.
    Felberg S; Dantas PEC; Sato EH
    Arq Bras Oftalmol; 2022; 85(3):269-276. PubMed ID: 34909917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the first tear film break-up point in Sjögren's syndrome and non-Sjögren's syndrome dry eye patients.
    Zhao S; Le Q
    BMC Ophthalmol; 2022 Jan; 22(1):1. PubMed ID: 34980014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral pilocarpine for the treatment of ocular symptoms in patients with Sjögren's syndrome: a randomised 12 week controlled study.
    Tsifetaki N; Kitsos G; Paschides CA; Alamanos Y; Eftaxias V; Voulgari PV; Psilas K; Drosos AA
    Ann Rheum Dis; 2003 Dec; 62(12):1204-7. PubMed ID: 14644860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between systemic activity ındex and dry eye severity in patients with primary Sjögren syndrome.
    Ozek D; Kemer OE; Omma A
    Arq Bras Oftalmol; 2019; 82(1):45-50. PubMed ID: 30403265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Oral Pilocarpine in Treating Severe Dry Eye in Patients With Sjögren Syndrome.
    Kawakita T; Shimmura S; Tsubota K
    Asia Pac J Ophthalmol (Phila); 2015; 4(2):101-5. PubMed ID: 26065354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with ocular surface epithelial damage in patients with primary Sjögren's syndrome.
    Kim JE; Kim NR; Chin HS; Seo KY; Kim TI; Jung JW
    BMC Ophthalmol; 2021 Mar; 21(1):114. PubMed ID: 33653304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of ocular surface status and function in primary Sjögren's syndrome with hypothyroidism].
    Yu HZ; Zeng WZ; Wu WY; Yao ZQ; Feng Y
    Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Aug; 54(4):705-711. PubMed ID: 35950396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the NEI-VFQ and OSDI questionnaires in patients with Sjögren's syndrome-related dry eye.
    Vitale S; Goodman LA; Reed GF; Smith JA
    Health Qual Life Outcomes; 2004 Sep; 2():44. PubMed ID: 15341657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autologous serum eye drops for dry eye.
    Pan Q; Angelina A; Marrone M; Stark WJ; Akpek EK
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD009327. PubMed ID: 28245347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of environmental pollution on the ocular surface of Sjögren's syndrome patients.
    Galperín G; Berra M; Marquez MI; Mandaradoni M; Tau J; Berra A
    Arq Bras Oftalmol; 2018 Nov./Dec.; 81(6):481-489. PubMed ID: 30231159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three percent diquafosol ophthalmic solution as an additional therapy to existing artificial tears with steroids for dry-eye patients with Sjögren's syndrome.
    Yokoi N; Sonomura Y; Kato H; Komuro A; Kinoshita S
    Eye (Lond); 2015 Sep; 29(9):1204-12. PubMed ID: 26160526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severity of clinical dry eye manifestations influences protein expression in tear fluid of patients with primary Sjögren's syndrome.
    Aqrawi LA; Chen X; Jensen JL; Morthen MK; Thiede B; Utheim ØA; Palm Ø; Tashbayev B; Utheim TP; Galtung HK
    PLoS One; 2018; 13(10):e0205762. PubMed ID: 30312344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of Sjögren's syndrome-associated dry eye an evidence-based review.
    Akpek EK; Lindsley KB; Adyanthaya RS; Swamy R; Baer AN; McDonnell PJ
    Ophthalmology; 2011 Jul; 118(7):1242-52. PubMed ID: 21459453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Sjögren's syndrome dry eye using 0.03% tacrolimus eye drop: Prospective double-blind randomized study.
    Moscovici BK; Holzchuh R; Sakassegawa-Naves FE; Hoshino-Ruiz DR; Albers MB; Santo RM; Hida RY
    Cont Lens Anterior Eye; 2015 Oct; 38(5):373-8. PubMed ID: 25956572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tear osmolarity measurements in dry eye related to primary Sjögren's syndrome.
    Utine CA; Bıçakçıgil M; Yavuz S; Çiftçi F
    Curr Eye Res; 2011 Aug; 36(8):683-90. PubMed ID: 21780917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical cyclosporine a (0.05%) treatment in dry eye patients: a comparison study of Sjogren's syndrome versus non-Sjogren's syndrome.
    Cubuk MO; Ucgul AY; Ozgur A; Ozulken K; Yuksel E
    Int Ophthalmol; 2021 Apr; 41(4):1479-1485. PubMed ID: 33484384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Autologous serum tears: Long-term treatment in dry eye syndrome].
    Beylerian M; Lazaro M; Magalon J; Veran J; Darque A; Grimaud F; Stolowy N; Beylerian H; Sabatier F; Hoffart L
    J Fr Ophtalmol; 2018 Mar; 41(3):246-254. PubMed ID: 29602451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tear Osmolarity and Matrix Metallopeptidase-9 in Dry Eye Associated with Sjögren's Syndrome.
    Kook KY; Jin R; Li L; Yoon HJ; Yoon KC
    Korean J Ophthalmol; 2020 Jun; 34(3):179-186. PubMed ID: 32495525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conjunctival epithelium improvement after systemic pilocarpine in patients with Sjogren's syndrome.
    Aragona P; Di Pietro R; Spinella R; Mobrici M
    Br J Ophthalmol; 2006 Feb; 90(2):166-70. PubMed ID: 16424527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corneal subbasal nerve analysis in patients with primary Sjogren's syndrome: a novel objective grading method and clinical correlations.
    Hao R; Chou Y; Ding Y; Liu Z; Wang Y; Ren X; Li X
    Int Ophthalmol; 2023 Mar; 43(3):779-793. PubMed ID: 36056289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.